8-K: American Vanguard Receives NYSE Noncompliance Notice Due to Delayed 10-K Filing

American Vanguard Corporation received a notice from the NYSE regarding noncompliance with listing standards due to a delay in filing its annual report, and has amended its credit facility to extend the deadline for providing audited financial statements.

Summary

• American Vanguard Corporation (AVD) received a notice from the New York Stock Exchange (NYSE) on April 2, 2025, indicating noncompliance with Section 802.01E of the NYSE Listed Company Manual because the company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
• The NYSE has granted the company up to six months from March 31, 2025, to file the Form 10-K and regain compliance.
• AVD intends to file the Form 10-K in the near future and expects its common stock to continue to be listed on the NYSE during this period.
• There is no assurance that the company will ultimately regain and remain in compliance with all applicable NYSE listing standards.
• On March 31, 2025, AMVAC Chemical Corporation, a subsidiary of American Vanguard, entered into Amendment Number Nine to its Loan and Security Agreement, extending the due date for delivering audited financial statements for the fiscal year ended December 31, 2024, from 90 days to 120 days following the end of the fiscal year.
• The amendment does not change the 90-day period for future fiscal years.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the NYSE noncompliance notice and the delay in filing the Form 10-K, raising concerns about the company's financial reporting and internal controls.

Positives

• The NYSE has granted the company a six-month period to regain compliance by filing the overdue Form 10-K.
• The company expects its common stock to continue to be listed on the NYSE while it works to complete the filing.
• The amendment to the credit facility provides the company with additional time to complete its year-end reporting process.

Negatives

• The company is not in compliance with NYSE listing standards due to the delayed filing of its Form 10-K.
• There is no guarantee that the company will regain and maintain compliance with NYSE listing standards.
• The company determined it would not be able to file the Form 10-K within the 15-day extension period under Rule 12b-25 and needs additional time, resources and effort to complete its year-end reporting process.

Risks

• Failure to file the Form 10-K within the six-month period could result in delisting from the NYSE.
• The delay in filing the Form 10-K may indicate underlying issues with the company's financial reporting processes.
• There is a risk that the company may not be able to regain and remain in compliance with all applicable NYSE listing standards.

Future Outlook

The company expects to file its Form 10-K in the near future and anticipates that its common stock will continue to be listed on the NYSE. However, the company acknowledges that there is no assurance it will regain and remain in compliance with all applicable NYSE listing standards.

Management Comments

• The Company determined it would not be able to file the Form 10-K within the 15-day extension period under Rule 12b-25 and needs additional time, resources and effort to complete its year-end reporting process.
• Accordingly, the Company is working diligently to complete the necessary work to make the filing as soon as possible.

Industry Context

Delays in financial reporting can erode investor confidence and raise concerns about a company's internal controls and financial health. This situation could potentially impact American Vanguard's standing within the specialty and agriculture products industry, especially if competitors are meeting their reporting deadlines without issue.

Comparison to Industry Standards

• It is difficult to compare American Vanguard's situation to specific industry standards without knowing the exact reasons for the delay in filing the Form 10-K.
• However, timely financial reporting is a fundamental expectation for publicly listed companies, and delays are generally viewed negatively by investors and regulators.
• Companies like FMC Corporation, Corteva, and Bayer Crop Science are expected to adhere to strict reporting timelines, and any deviation could raise concerns.

Stakeholder Impact

• Shareholders may be concerned about the delay in filing the Form 10-K and the potential impact on the company's stock price.
• Employees may experience uncertainty due to the company's noncompliance with NYSE listing standards.
• Creditors may reassess their risk exposure due to the delay in financial reporting.

Next Steps

• The company intends to file the Form 10-K in the near future.
• The company must complete the filing within six months from March 31, 2025, to regain compliance with NYSE listing standards.

Key Dates

Keywords

Form 10-K, NYSE, noncompliance, filing delay, American Vanguard, AMVAC, loan agreement, financial statements, compliance